2/3
07:00 am
elv
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
Low
Report
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
2/3
07:00 am
elv
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
Low
Report
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
2/3
06:38 am
elv
Elevance Health downgraded to Sector Perform from Outperform at RBC Capital
Low
Report
Elevance Health downgraded to Sector Perform from Outperform at RBC Capital
2/3
06:38 am
elv
Elevance Health downgraded to Sector Perform from Outperform at RBC Capital
Low
Report
Elevance Health downgraded to Sector Perform from Outperform at RBC Capital
2/2
12:52 pm
elv
Rating for ELV
Low
Report
Rating for ELV
1/30
10:59 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/30
10:59 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/30
10:18 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/30
10:18 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/29
09:48 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/29
09:48 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/22
09:12 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/22
09:12 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/22
07:19 am
elv
Elevance Health (NYSE:ELV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Elevance Health (NYSE:ELV) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/22
07:19 am
elv
Elevance Health (NYSE:ELV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Elevance Health (NYSE:ELV) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/9
06:10 am
elv
Elevance Health (NYSE:ELV) was upgraded by analysts at Wolfe Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Elevance Health (NYSE:ELV) was upgraded by analysts at Wolfe Research from a "hold" rating to a "strong-buy" rating.
1/9
06:10 am
elv
Elevance Health (NYSE:ELV) was upgraded by analysts at Wolfe Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Elevance Health (NYSE:ELV) was upgraded by analysts at Wolfe Research from a "hold" rating to a "strong-buy" rating.
1/8
07:50 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/8
07:50 am
elv
Rating for ELV
Low
Report
Rating for ELV
1/8
05:00 am
elv
Elevance Health upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Elevance Health upgraded to Outperform from Peer Perform at Wolfe Research
1/8
05:00 am
elv
Elevance Health upgraded to Outperform from Peer Perform at Wolfe Research
Low
Report
Elevance Health upgraded to Outperform from Peer Perform at Wolfe Research
1/7
04:05 pm
elv
Rating for ELV
Low
Report
Rating for ELV
1/7
04:05 pm
elv
Rating for ELV
Low
Report
Rating for ELV
1/7
08:02 am
elv
Elevance Health (NYSE:ELV) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Elevance Health (NYSE:ELV) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
1/6
10:06 am
elv
Elevance Health (NYSE:ELV) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Elevance Health (NYSE:ELV) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.